scholarly journals Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia

2021 ◽  
pp. clincanres.1295.2021
Author(s):  
Eytan M. Stein ◽  
Daniel J DeAngelo ◽  
Jörg Chromik ◽  
Manik Chatterjee ◽  
Sebastian Bauer ◽  
...  
Keyword(s):  
Acute Leukemia ◽  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Wild Type

A phase I study of the MDM2 inhibitor AMG 232 in patients with advanced p53 wild type (p53WT) solid tumors or multiple myeloma

2016 ◽  
Vol 69 ◽  
pp. S34 ◽  
Author(s):  
M.H. Langenberg ◽  
L. Gluck ◽  
V. Weger ◽  
R. Frank ◽  
F. Eskens ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Wild Type ◽  
Mdm2 Inhibitor

Vorolanib (X-82), an oral anti-VEGFR/PDGFR/CSF1R tyrosine kinase inhibitor, with everolimus in solid tumors: results of a phase I study

2021 ◽  
Author(s):  
Katrina S. Pedersen ◽  
Patrick M. Grierson ◽  
Joel Picus ◽  
A. Craig Lockhart ◽  
Bruce J. Roth ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Phase I ◽  
Tyrosine Kinase Inhibitor ◽  
Solid Tumors ◽  
Phase I Study ◽  
Kinase Inhibitor

A phase I study of the human monoclonal anti-NRP1 antibody MNRP1685A in patients with advanced solid tumors

2014 ◽  
Vol 32 (4) ◽  
pp. 653-660 ◽  
Author(s):  
Colin D. Weekes ◽  
Muralidhar Beeram ◽  
Anthony W. Tolcher ◽  
Kyriakos P. Papadopoulos ◽  
Lia Gore ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Advanced Solid Tumors

scholarly journals A phase I study of Triapine® in combination with doxorubicin in patients with advanced solid tumors

2008 ◽  
Vol 63 (6) ◽  
pp. 1147-1156 ◽  
Author(s):  
William R. Schelman ◽  
Sherry Morgan-Meadows ◽  
Rebecca Marnocha ◽  
Fred Lee ◽  
Jens Eickhoff ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Advanced Solid Tumors

23 Phase I study of lurbinectedin (PM01183) administered on days (D) 1 & 8 every 3 weeks (q3wk) in patients (pts) with solid tumors

2014 ◽  
Vol 50 ◽  
pp. 13-14 ◽  
Author(s):  
M.J. Ratain ◽  
L. Gore ◽  
S. Szyldergemajn ◽  
J. Diamond ◽  
D. Geary ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study

scholarly journals Erratum to: Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics

2013 ◽  
Vol 32 (2) ◽  
pp. 388-388
Author(s):  
Yu Sunakawa ◽  
Junji Furuse ◽  
Takuji Okusaka ◽  
Masafumi Ikeda ◽  
Fumio Nagashima ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Japanese Patients
Sign in / Sign up

Export Citation Format

Share Document